{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T22:39:12Z","timestamp":1792276752388,"version":"4.4.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T00:00:00Z","timestamp":1647475200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T00:00:00Z","timestamp":1647475200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100005788","name":"Medical University of Vienna","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005788","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s10620-022-07443-6","type":"journal-article","created":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T19:04:55Z","timestamp":1647543895000},"page":"5693-5703","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Covered Transjugular Intrahepatic Portosystemic Shunt Improves Hypersplenism-Associated Cytopenia in Cirrhosis"],"prefix":"10.1007","volume":"67","author":[{"given":"Theresa","family":"Bucsics","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Lampichler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantin","family":"Vierziger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Schoder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedikt","family":"Simbrunner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Hartl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Jachs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Scheiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Trauner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Gruenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz","family":"Karnel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattias","family":"Mandorfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4590-3583","authenticated-orcid":false,"given":"Thomas","family":"Reiberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,17]]},"reference":[{"key":"7443_CR1","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver (EASL). EASL clinical practice guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;69:406\u2013460.","DOI":"10.1016\/j.jhep.2018.03.024"},{"key":"7443_CR2","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1111\/j.1445-5994.1990.tb00421.x","volume":"20","author":"PR Gibson","year":"1990","unstructured":"Gibson PR, Gibson RN, Ditchfield MR, Donlan JD. Splenomegaly\u2014an insensitive sign of portal hypertension. Aust N Z J Med. 1990;20:771\u2013774.","journal-title":"Aust N Z J Med."},{"key":"7443_CR3","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1002\/1097-0096(200009)28:7<332::AID-JCU3>3.0.CO;2-9","volume":"28","author":"A Von Herbay","year":"2000","unstructured":"Von Herbay A, Frieling T, H\u00e4ussinger D. Color doppler sonographic evaluation of spontaneous portosystemic shunts and inversion of portal venous flow in patients with cirrhosis. J Clin Ultrasound. 2000;28:332\u2013339.","journal-title":"J Clin Ultrasound."},{"key":"7443_CR4","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1586\/egh.12.83","volume":"7","author":"A Berzigotti","year":"2013","unstructured":"Berzigotti A, Seijo S, Reverter E, Bosch J. Assessing portal hypertension in liver diseases. Expert Rev Gastroenterol Hepatol. 2013;7:141\u2013155.","journal-title":"Expert Rev Gastroenterol Hepatol."},{"key":"7443_CR5","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s12013-014-9920-9","volume":"70","author":"Y Lv","year":"2014","unstructured":"Lv Y, Gong X, Xie X, Wang B, Yang Y, Li Y. Clinical study on the relationship between hematocytopenia and splenomegaly caused by cirrhotic portal hypertension. Cell Biochem Biophys. 2014;70:355\u2013360.","journal-title":"Cell Biochem Biophys."},{"key":"7443_CR6","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/liv.14229","volume":"40","author":"B Scheiner","year":"2020","unstructured":"Scheiner B, Semmler G, Maurer F, Schwabl P, Bucsics TA, Paternostro R et al. Prevalence of and risk factors for anaemia in patients with advanced chronic liver disease. Liver Int. 2020;40:194\u2013204.","journal-title":"Liver Int."},{"key":"7443_CR7","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.cgh.2009.02.021","volume":"7","author":"AA Qamar","year":"2009","unstructured":"Qamar AA, Grace ND, Groszmann RJ, Garcia-Tsao G, Bosch J, Burroughs AK et al. Incidence, prevalence, and clinical significance of abnormal hematologic indices in compensated cirrhosis. Clin Gastroenterol Hepatol. 2009;7:689\u2013695.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"7443_CR8","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1177\/1535370217693113","volume":"242","author":"Y Lv","year":"2017","unstructured":"Lv Y, Yee Lau W, Wu H, Han XY, Gong X, Liu N et al. Causes of peripheral cytopenia in hepatitic cirrhosis and portal hypertensive splenomegaly. Exp Biol Med. 2017;242:744\u2013749.","journal-title":"Exp Biol Med."},{"key":"7443_CR9","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1111\/liv.13317","volume":"37","author":"M Peck-Radosavljevic","year":"2017","unstructured":"Peck-Radosavljevic M. Thrombocytopenia in chronic liver disease. Liver Int. 2017;37:778\u2013793.","journal-title":"Liver Int."},{"key":"7443_CR10","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1111\/liv.14273","volume":"40","author":"M Mandorfer","year":"2020","unstructured":"Mandorfer M, Peck-Radosavljevic M, Ferenci P, Reiberger T. Dynamics of platelet count after sustained virologic response do not mirror those of hepatic venous pressure gradient. Liver Int. 2020;40:988\u2013989.","journal-title":"Liver Int."},{"key":"7443_CR11","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1067\/mlc.2001.119106","volume":"138","author":"S Maruyama","year":"2001","unstructured":"Maruyama S, Hirayama C, Yamamoto S, Koda M, Udagawa A, Kadowaki Y et al. Red blood cell status in alcoholic and non-alcoholic liver disease. J Lab Clin Med. 2001;138:332\u2013337.","journal-title":"J Lab Clin Med."},{"key":"7443_CR12","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1111\/liv.13971","volume":"39","author":"N Pfisterer","year":"2019","unstructured":"Pfisterer N, Riedl F, Pachofszky T, Gschwantler M, K\u00f6nig K, Schuster B et al. Outcomes after placement of a SX-ELLA oesophageal stent for refractory variceal bleeding\u2014a national multicentre study. Liver Int. 2019;39:290\u2013298.","journal-title":"Liver Int."},{"key":"7443_CR13","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.3748\/wjg.v20.i10.2595","volume":"20","author":"H Hayashi","year":"2014","unstructured":"Hayashi H, Beppu T, Shirabe K, Maehara Y, Baba H. Management of thrombocytopenia due to liver cirrhosis: a review. World J Gastroenterol. 2014;20:2595\u20132605.","journal-title":"World J Gastroenterol."},{"key":"7443_CR14","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","volume":"63","author":"R de Franchis","year":"2015","unstructured":"de Franchis R, On behalf of the Baveno VI Faculty. Expanding consensus in portal hypertension: report of the baveno VI consensus workshop: stratifying risk and individualizing care for portal hypertension. J Hepatol. 2015;63:743\u2013752.","journal-title":"J Hepatol."},{"key":"7443_CR15","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1053\/j.gastro.2012.10.001","volume":"144","author":"A Berzigotti","year":"2013","unstructured":"Berzigotti A, Seijo S, Arena U, Abraldes JG, Vizzutti F, Garc\u00eda-Pag\u00e1n JC et al. Elastography, spleen size, and platelet count identify portal hypertension in patients with compensated cirrhosis. Gastroenterology. 2013;144:102-111.e1.","journal-title":"Gastroenterology."},{"key":"7443_CR16","doi-asserted-by":"publisher","first-page":"308","DOI":"10.3748\/wjg.v25.i3.308","volume":"25","author":"R Paternostro","year":"2019","unstructured":"Paternostro R, Reiberger T, Bucsics T. Elastography-based screening for esophageal varices in patients with advanced chronic liver disease. World J Gastroenterol. 2019;25:308\u2013329.","journal-title":"World J Gastroenterol."},{"key":"7443_CR17","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s00508-017-1262-3","volume":"129","author":"T Reiberger","year":"2017","unstructured":"Reiberger T, P\u00fcsp\u00f6k A, Schoder M, Baumann-Durchschein F, Bucsics T, Datz C et al. Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth III). Wien Klin Wochenschr. 2017;129:135\u2013158.","journal-title":"Wien Klin Wochenschr."},{"key":"7443_CR18","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1111\/liv.13615","volume":"38","author":"T Bucsics","year":"2018","unstructured":"Bucsics T, Hoffman S, Gr\u00fcnberger J, Schoder M, Matzek W, Stadlmann A et al. ePTFE-TIPS vs repetitive LVP plus albumin for the treatment of refractory ascites in patients with cirrhosis. Liver Int. 2018;38:1036\u20131044.","journal-title":"Liver Int."},{"key":"7443_CR19","doi-asserted-by":"crossref","unstructured":"Bucsics T, Schoder M, Diermayr M, Feldner-Busztin M, Goeschl N, Bauer D et al. Transjugular intrahepatic portosystemic shunts (TIPS) for the prevention of variceal re-bleeding \u2013 A two decades experience. PLoS One. 2018;9:1\u201315.","DOI":"10.1371\/journal.pone.0189414"},{"key":"7443_CR20","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1002\/hep.30561","volume":"70","author":"M Peck-Radosavljevic","year":"2019","unstructured":"Peck-Radosavljevic M, Simon K, Iacobellis A, Hassanein T, Kayali Z, Tran A et al. Lusutrombopag for the treatment of thrombocytopenia in patients with chronic liver disease undergoing invasive procedures (L-PLUS 2). Hepatology. 2019;70:1336\u20131348.","journal-title":"Hepatology."},{"key":"7443_CR21","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.dld.2008.10.005","volume":"41","author":"K Zhu","year":"2009","unstructured":"Zhu K, Meng X, Qian J, Huang M, Li Z, Guan S et al. Partial splenic embolization for hypersplenism in cirrhosis: a long-term outcome in 62 patients. Dig Liver Dis. 2009;41:411\u2013416.","journal-title":"Dig Liver Dis."},{"key":"7443_CR22","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1177\/004947559702700228","volume":"27","author":"UC Pandey","year":"1997","unstructured":"Pandey UC, Jussa ZM, Qureshi IM, Al-Dhohayan A, Shareef ZA. Partial splenic embolization for the treatment of hypersplenism in tropical splenomegaly. Trop Doct. 1997;27:114\u2013115.","journal-title":"Trop Doct."},{"key":"7443_CR23","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/S0168-8278(99)80071-3","volume":"30","author":"M Gschwantler","year":"1999","unstructured":"Gschwantler M, Vavrik J, Gebauer A, Kriwanek S, Schrutka-K\u00f6lbl C, Fleischer J et al. Course of platelet counts in cirrhotic patients after implantation of a transjugular intrahepatic portosystemic shunt - a prospective, controlled study. J Hepatol. 1999;30:254\u2013259.","journal-title":"J Hepatol."},{"key":"7443_CR24","first-page":"286","volume":"13","author":"OI Massoud","year":"2017","unstructured":"Massoud OI, Zein NN. The effect of transjugular intrahepatic portosystemic shunt on platelet counts in patients with liver cirrhosis. Gastroenterol Hepatol. 2017;13:286\u2013291.","journal-title":"Gastroenterol Hepatol."},{"key":"7443_CR25","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1007\/s10620-012-2162-z","volume":"57","author":"EJ Barney","year":"2012","unstructured":"Barney EJ, Little EC, Gerkin RD, Ramos AX, Kahn J, Wong M et al. Coated transjugular intrahepatic portosystemic shunt does not improve thrombocytopenia in patients with liver cirrhosis. Dig Dis Sci. 2012;57:2430\u20132437.","journal-title":"Dig Dis Sci."},{"key":"7443_CR26","unstructured":"UNOS. OPTN\/UNOS policy note. 29072019 2016:1\u201323. https:\/\/optn.transplant.hrsa.gov\/media\/1575\/policynotice_20151101.pdf Accessed 13.12.2020."},{"key":"7443_CR27","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1007\/s00508-013-0337-z","volume":"125","author":"M Peck-Radosavljevic","year":"2013","unstructured":"Peck-Radosavljevic M, Angermayr B, Datz C, Ferlitsch A, Ferlitsch M, Fuhrmann V et al. Austrian consensus on the definition and treatment of portal hypertension and its complications (Billroth II). Wien Klin Wochenschr. 2013;125:200\u2013219.","journal-title":"Wien Klin Wochenschr."},{"key":"7443_CR28","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1016\/j.dld.2017.08.002","volume":"49","author":"T Bucsics","year":"2017","unstructured":"Bucsics T, Schoder M, Goeschl N, Schwabl P, Mandorfer M, Diermayr M et al. Re-bleeding rates and survival after early transjugular intrahepatic portosystemic shunt (TIPS) in clinical practice. Dig Liver Dis. 2017;49:1360\u20131367.","journal-title":"Dig Liver Dis."},{"key":"7443_CR29","doi-asserted-by":"publisher","first-page":"317","DOI":"10.2214\/ajr.159.2.1632346","volume":"159","author":"JL Chezmar","year":"1992","unstructured":"Chezmar JL, Redvanly RD, Nelson RC, Henderson JM. Persistence of portosystemic collaterals and splenomegaly on CT after orthotopic liver transplantation. Am J Roentgenol. 1992;159:317\u2013320.","journal-title":"Am J Roentgenol."},{"key":"7443_CR30","doi-asserted-by":"crossref","unstructured":"Se HK, Lee JM, Jin YC, Suh KS, Yi NJ, Joon KH et al. Changes of portosystemic collaterals and splenic volume on CT after liver transplantation and factors influencing those changes. Am J Roentgenol. 2008;191:W8\u2013W16.","DOI":"10.2214\/AJR.07.2990"},{"key":"7443_CR31","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1007\/s00268-009-0314-x","volume":"34","author":"F Chikamori","year":"2010","unstructured":"Chikamori F, Nishida S, Selvaggi G, Tryphonopoulos P, Moon JI, Levi DM et al. Effect of liver transplantation on spleen size, collateral veins, and platelet counts. World J Surg. 2010;34:320\u2013326.","journal-title":"World J Surg."},{"key":"7443_CR32","unstructured":"Liu J, Ma J, Yang C, Ye T, Meng J, Shi Q, et al. Impact of TIPS on splenic volume and thrombocytopenia. Am J Roentgenol. 2021:1\u20136."},{"key":"7443_CR33","first-page":"379","volume":"70","author":"S Monteiro","year":"2021","unstructured":"Monteiro S, Grandt J, Uschner FE, Kimer N, Madsen JL, Schierwagen R et al. Differential inflammasome activation predisposes to acute-on-chronic liver failure in human and experimental cirrhosis with and without previous decompensation. Gut. 2021;70:379\u2013387.","journal-title":"Gut."},{"key":"7443_CR34","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1016\/j.jhep.2015.07.004","volume":"63","author":"M Bernardi","year":"2015","unstructured":"Bernardi M, Moreau R, Angeli P, Schnabl B. Mechanisms of decompensation and organ failure in cirrhosis: from peripheral arterial vasodilation to systemic inflammation hypothesis. J Hepatol. 2015;63:1272\u20131284.","journal-title":"J Hepatol."},{"key":"7443_CR35","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.jhep.2020.10.004","volume":"74","author":"D Costa","year":"2021","unstructured":"Costa D, Simbrunner B, Jachs M, Hartl L, Bauer D, Paternostro R et al. Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality. J Hepatol. 2021;74:819\u2013828.","journal-title":"J Hepatol."},{"key":"7443_CR36","doi-asserted-by":"crossref","unstructured":"Jachs M, Hartl L, Schaufler D, Desbalmes C, Simbrunner B, Eigenbauer E et al. Amelioration of systemic inflammation in advanced chronic liver disease upon beta-blocker therapy translates into improved clinical outcomes. Gut. 2021;70:1758\u20131767.","DOI":"10.1136\/gutjnl-2020-322712"},{"key":"7443_CR37","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.cld.2021.01.009","volume":"25","author":"P Ferstl","year":"2021","unstructured":"Ferstl P, Trebicka J. Acute decompensation and acute-on-chronic liver failure. Clin Liver Dis. 2021;25:419\u2013430.","journal-title":"Clin Liver Dis."},{"key":"7443_CR38","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.jhep.2020.11.048","volume":"74","author":"V Arroyo","year":"2021","unstructured":"Arroyo V, Angeli P, Moreau R, Jalan R, Cl\u00e0ria J, Trebicka J et al. The systemic inflammation hypothesis: towards a new paradigm of acute decompensation and multiorgan failure in cirrhosis. J Hepatol. 2021;74:670\u2013685.","journal-title":"J Hepatol."},{"key":"7443_CR39","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.cld.2021.01.003","volume":"25","author":"M Mandorfer","year":"2021","unstructured":"Mandorfer M, Simbrunner B. Prevention of first decompensation in advanced chronic liver disease. Clin Liver Dis. 2021;25:291\u2013310.","journal-title":"Clin Liver Dis."},{"key":"7443_CR40","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.jhep.2016.10.025","volume":"66","author":"J Trebicka","year":"2017","unstructured":"Trebicka J. Emergency TIPS in a Child-Pugh B patient: when does the window of opportunity open and close? J Hepatol. 2017;66:442\u2013450.","journal-title":"J Hepatol."},{"key":"7443_CR41","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.jhep.2012.12.011","volume":"58","author":"T Reiberger","year":"2013","unstructured":"Reiberger T, Ferlitsch A, Payer BA, Mandorfer M, Heinisch BB, Hayden H et al. Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis. J Hepatol. 2013;58:911\u2013921.","journal-title":"J Hepatol."},{"key":"7443_CR42","first-page":"20","volume":"69","author":"A Queck","year":"2019","unstructured":"Queck A, Carnevale R, Uschner FE, Schierwagen R, Klein S, Jansen C et al. Role of portal venous platelet activation in patients with decompensated cirrhosis and TIPS. Gut. 2019;69:20\u201321.","journal-title":"Gut."},{"key":"7443_CR43","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1056\/NEJMoa0910102","volume":"362","author":"JC Garc\u00eda-Pag\u00e1n","year":"2010","unstructured":"Garc\u00eda-Pag\u00e1n JC, Caca K, Bureau C, Laleman W, Appenrodt B, Luca A et al. Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med. 2010;362:2370\u20132379.","journal-title":"N Engl J Med."},{"key":"7443_CR44","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/S2468-1253(19)30090-1","volume":"4","author":"Y Lv","year":"2019","unstructured":"Lv Y, Yang Z, Liu L, Li K, He C, Wang Z et al. Early TIPS with covered stents versus standard treatment for acute variceal bleeding in patients with advanced cirrhosis: a randomised controlled trial. Lancet Gastroenterol Hepatol. 2019;4:587\u2013598.","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"7443_CR45","doi-asserted-by":"publisher","unstructured":"Trebicka J, Gu W, Ib\u00e1\u00f1ez-Samaniego L, Hern\u00e1ndez-Gea V, Pitarch C, Garcia E et al. Rebleeding and mortality risk are increased by ACLF but reduced by pre-emptive\nTIPS. J Hepatol. 2020;73:1082\u20131091. https:\/\/doi.org\/10.1016\/j.jhep.2020.04.024.","DOI":"10.1016\/j.jhep.2020.04.024"},{"key":"7443_CR46","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1002\/hep.29612","volume":"67","author":"C Jansen","year":"2018","unstructured":"Jansen C, M\u00f6ller P, Meyer C, Kolbe CC, Bogs C, Pohlmann A et al. Increase in liver stiffness after transjugular intrahepatic portosystemic shunt is associated with inflammation and predicts mortality. Hepatology. 2018;67:1472\u20131484.","journal-title":"Hepatology."},{"key":"7443_CR47","first-page":"305","volume":"5","author":"K Ansari-Gilani","year":"2017","unstructured":"Ansari-Gilani K, Tonekaboni BS, Nakamoto DA, Esfeh JM. Utility of Doppler ultrasonography for predicting improvement of platelet count after transjugular intrahepatic portosystemic shunt. Gastroenterol Rep. 2017;5:305\u2013308.","journal-title":"Gastroenterol Rep."},{"key":"7443_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00508-019-01593-w","volume":"132","author":"B Simbrunner","year":"2020","unstructured":"Simbrunner B, Beer A, W\u00f6ran K, Schmitz F, Primas C, Wewalka M et al. Portal hypertensive gastropathy is associated with iron deficiency anemia. Wien Klin Wochenschr. 2020;132:1\u201311.","journal-title":"Wien Klin Wochenschr."},{"key":"7443_CR49","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.jhep.2010.08.025","volume":"54","author":"C Bureau","year":"2011","unstructured":"Bureau C, M\u00e9tivier S, D\u2019Amico M, P\u00e9ron JM, Otal P, Pagan JCG et al. Serum bilirubin and platelet count: a simple predictive model for survival in patients with refractory ascites treated by TIPS. J Hepatol. 2011;54:901\u2013907.","journal-title":"J Hepatol."},{"key":"7443_CR50","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.jhep.2020.10.004","volume":"74","author":"D Costa","year":"2020","unstructured":"Costa D, Simbrunner B, Jachs M, Hartl L, Bauer D, Paternostro R et al. Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality. J Hepatol. 2020;74:819\u2013828.","journal-title":"J Hepatol."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-022-07443-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-022-07443-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-022-07443-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T21:11:09Z","timestamp":1668201069000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-022-07443-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,17]]},"references-count":50,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["7443"],"URL":"https:\/\/doi.org\/10.1007\/s10620-022-07443-6","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,17]]},"assertion":[{"value":"23 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Mattias Mandorfer served as a speaker and\/or consultant and\/or advisory board member for W.L. Gore and Associates. Thomas Reiberger received grant support and speaking honoraria from W.L. Gore and Associates. Maria Schoder served as a speaker and\/or consultant and\/or advisory board member for W.L. Gore and Associates.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and its later amendments. It was approved by the Ethics Committees of the Medical University of Vienna (1760\/2014) and of the City of Vienna (MA15, 14\u2013264-VK). This research study was conducted retrospectively from data obtained for clinical purposes, and all the procedures being performed were part of the routine care. Due to the retrospective nature of the study, the need for informed patient consent was waived by the local Ethics Committees.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}